Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Assess the effect on immunogenicity of administration of vaccine without buffering agent and assess heat stability in terms of immunogenicity, reactogenicity and safety of GSK [GlaxoSmithKline] Biologicals' oral live attenuated human rotavirus vaccine following a 0 2 month schedule in healthy infants previously uninfected with human rotavirus.

Trial Profile

Assess the effect on immunogenicity of administration of vaccine without buffering agent and assess heat stability in terms of immunogenicity, reactogenicity and safety of GSK [GlaxoSmithKline] Biologicals' oral live attenuated human rotavirus vaccine following a 0 2 month schedule in healthy infants previously uninfected with human rotavirus.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 08 Sep 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rotavirus vaccine (Primary)
  • Indications Rotavirus infections
  • Focus Pharmacodynamics; Registrational
  • Sponsors GlaxoSmithKline; GSK
  • Most Recent Events

    • 09 Oct 2008 Checked against ClinicalTrials.gov record - last updated 9 Oct 2008.
    • 13 Apr 2007 Results have been reported.
    • 06 Nov 2006 Status change
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top